Jamie Wine

Jamie Wine is one of the nation’s leading trial lawyers and a Fellow in the American College of Trial Lawyers. She has deep experience in complex commercial litigation, securities litigation, and SEC and other regulatory matters. Her recent wins include a trial victory in Delaware Chancery Court for Scilex Pharmaceuticals in a breach of fiduciary duty and misappropriation of trade secrets case; prevailing in an arbitration for John Paul Mitchell Systems in a several hundred million dollar contract dispute; the dismissal of a highly-publicized defamation lawsuit against Chess.com relating to a grandmaster cheating scandal; and winning US$666 million in a post-M&A dispute for DXC Corporation.

Widely praised for her excellence, Jamie was recognized by The American Lawyer as a finalist for Litigator of the Year in 2020. Benchmark Litigation consistently includes her in its Top 100 Trial Lawyer and Top 250 Women in Litigation lists. Chambers USA recognizes Jamie in both its leading commercial trial lawyer and securities litigator categories. She has been included for several years in Lawdragon’s 500 Leading Lawyers in America list and was named to its 2025 500 Leading Global Entertainment, Sports & Media Lawyers guide and 2023 Legends of the 500. Crain’s New York Business also has recognized Jamie as a Leading Women Lawyer in New York City. Clients say Jamie is “an outstanding trial lawyer” and a “go-to lawyer on bet the company and other significant civil litigation,” and that she “exudes confidence” and “has good rapport with judges and juries.”

Jamie formerly served as Global Chair of Latham’s Litigation & Trial Department and prior to that as a member of the firm’s Executive Committee.

Updated Oct 2025

• Lead trial counsel for AIG Financial Products in a Delaware Bankruptcy Court adversary proceeding, in connection with its chapter 11 restructuring, regarding the treatment of debt related to pre-2008 financial crisis deferred compensation plans.
  
  
• Prevailed as lead trial counsel for John Paul Mitchell Systems, defeating primary wrongful termination claim brought by a contract manufacturer under an exclusive supply agreement, and winning on multiple counterclaims for breaches of contract, with attorneys’ fees and costs awarded to JPMS.
  
  
• Won complete dismissal, on a motion to dismiss, of a securities class action filed in the Northern District of California against Akero Therapeutics and certain of its officers and directors, alleging that the defendants had misled investors about the design of a clinical trial testing a pioneering liver drug.
  
  
• Won complete dismissal, on a motion to dismiss, of a securities class action filed in the Eastern District of Virginia against DXC Technology Company and several of its officers relating to statements made about its merger integration plans.
  
  
• Won plaintiffs-side trial victory in the Delaware Court of Chancery for Sorrento Therapeutics and Scilex Pharmaceuticals in breach of fiduciary duty, breach of contract, and misappropriation of trade secrets case.

• Commercial
• Commercial disputes
• Securities

JD - Harvard Law School - 1995

• New York - 2007
• District of Columbia - 2007
• California - 1996
• Vermont - 2020